550 related articles for article (PubMed ID: 14962945)
1. Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial.
Brown DL; Desai KK; Vakili BA; Nouneh C; Lee HM; Golub LM
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):733-8. PubMed ID: 14962945
[TBL] [Abstract][Full Text] [Related]
2. Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled study.
Bogaty P; Brophy JM; Noel M; Boyer L; Simard S; Bertrand F; Dagenais GR
Circulation; 2004 Aug; 110(8):934-9. PubMed ID: 15302800
[TBL] [Abstract][Full Text] [Related]
3. Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease.
Wu TC; Leu HB; Lin WT; Lin CP; Lin SJ; Chen JW
Eur J Clin Invest; 2005 Sep; 35(9):537-45. PubMed ID: 16128859
[TBL] [Abstract][Full Text] [Related]
4. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study.
Kinlay S; Schwartz GG; Olsson AG; Rifai N; Leslie SJ; Sasiela WJ; Szarek M; Libby P; Ganz P;
Circulation; 2003 Sep; 108(13):1560-6. PubMed ID: 12975259
[TBL] [Abstract][Full Text] [Related]
5. Adjunctive subantimicrobial dose doxycycline: effect on clinical parameters and gingival crevicular fluid transforming growth factor-beta levels in severe, generalized chronic periodontitis.
Gürkan A; Cinarcik S; Hüseyinov A
J Clin Periodontol; 2005 Mar; 32(3):244-53. PubMed ID: 15766366
[TBL] [Abstract][Full Text] [Related]
6. [Inflammation study in unstable angina and myocardial infarction without ST segment elevation. Value of ultra-sensitive C-reactive protein].
Borrás Pallé S; Gómez Martínez E; Romero Rodrigo A; Campos Ferrer C; Molina E; Valentín Segura V
An Med Interna; 2002 Jun; 19(6):283-8. PubMed ID: 12152386
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis.
Heeschen C; Dimmeler S; Hamm CW; Fichtlscherer S; Simoons ML; Zeiher AM;
J Am Coll Cardiol; 2005 Jan; 45(2):229-37. PubMed ID: 15653020
[TBL] [Abstract][Full Text] [Related]
8. The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.
Mohler ER; Ballantyne CM; Davidson MH; Hanefeld M; Ruilope LM; Johnson JL; Zalewski A;
J Am Coll Cardiol; 2008 Apr; 51(17):1632-41. PubMed ID: 18436114
[TBL] [Abstract][Full Text] [Related]
9. Comparision of high sensitivity C-reactive protein and matrix metalloproteinase 9 in patients with unstable angina between with and without significant coronary artery plaques.
Wang LX; Lü SZ; Zhang WJ; Song XT; Chen H; Zhang LJ
Chin Med J (Engl); 2011 Jun; 124(11):1657-61. PubMed ID: 21740772
[TBL] [Abstract][Full Text] [Related]
10. Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial.
Hudson MP; Armstrong PW; Ruzyllo W; Brum J; Cusmano L; Krzeski P; Lyon R; Quinones M; Theroux P; Sydlowski D; Kim HE; Garcia MJ; Jaber WA; Weaver WD
J Am Coll Cardiol; 2006 Jul; 48(1):15-20. PubMed ID: 16814643
[TBL] [Abstract][Full Text] [Related]
11. Subantimicrobial dose doxycycline as adjunctive treatment for periodontitis. A review.
Preshaw PM; Hefti AF; Jepsen S; Etienne D; Walker C; Bradshaw MH
J Clin Periodontol; 2004 Sep; 31(9):697-707. PubMed ID: 15312090
[TBL] [Abstract][Full Text] [Related]
12. Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes.
Heeschen C; Dimmeler S; Hamm CW; Fichtlscherer S; Boersma E; Simoons ML; Zeiher AM;
Circulation; 2003 Apr; 107(16):2109-14. PubMed ID: 12668510
[TBL] [Abstract][Full Text] [Related]
13. Effect of aspirin plus clopidogrel on inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome.
Chen YG; Xu F; Zhang Y; Ji QS; Sun Y; Lü RJ; Li RJ
Chin Med J (Engl); 2006 Jan; 119(1):32-6. PubMed ID: 16454979
[TBL] [Abstract][Full Text] [Related]
14. Effects of scaling and root planing and sub-antimicrobial dose doxycycline on oral and systemic biomarkers of disease in patients with both chronic periodontitis and coronary artery disease.
Tüter G; Kurtiş B; Serdar M; Aykan T; Okyay K; Yücel A; Toyman U; Pinar S; Cemri M; Cengel A; Walker SG; Golub LM
J Clin Periodontol; 2007 Aug; 34(8):673-81. PubMed ID: 17590156
[TBL] [Abstract][Full Text] [Related]
15. Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction.
Morrow DA; Wiviott SD; White HD; Nicolau JC; Bramucci E; Murphy SA; Bonaca MP; Ruff CT; Scirica BM; McCabe CH; Antman EM; Braunwald E
Circulation; 2009 Jun; 119(21):2758-64. PubMed ID: 19451347
[TBL] [Abstract][Full Text] [Related]
16. Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study.
Mosorin M; Juvonen J; Biancari F; Satta J; Surcel HM; Leinonen M; Saikku P; Juvonen T
J Vasc Surg; 2001 Oct; 34(4):606-10. PubMed ID: 11668312
[TBL] [Abstract][Full Text] [Related]
17. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.
Naghavi M; Libby P; Falk E; Casscells SW; Litovsky S; Rumberger J; Badimon JJ; Stefanadis C; Moreno P; Pasterkamp G; Fayad Z; Stone PH; Waxman S; Raggi P; Madjid M; Zarrabi A; Burke A; Yuan C; Fitzgerald PJ; Siscovick DS; de Korte CL; Aikawa M; Airaksinen KE; Assmann G; Becker CR; Chesebro JH; Farb A; Galis ZS; Jackson C; Jang IK; Koenig W; Lodder RA; March K; Demirovic J; Navab M; Priori SG; Rekhter MD; Bahr R; Grundy SM; Mehran R; Colombo A; Boerwinkle E; Ballantyne C; Insull W; Schwartz RS; Vogel R; Serruys PW; Hansson GK; Faxon DP; Kaul S; Drexler H; Greenland P; Muller JE; Virmani R; Ridker PM; Zipes DP; Shah PK; Willerson JT
Circulation; 2003 Oct; 108(15):1772-8. PubMed ID: 14557340
[TBL] [Abstract][Full Text] [Related]
18. Subantimicrobial-dose doxycycline and cytokine-chemokine levels in gingival crevicular fluid.
Emingil G; Gürkan A; Atilla G; Kantarci A
J Periodontol; 2011 Mar; 82(3):452-61. PubMed ID: 20932155
[TBL] [Abstract][Full Text] [Related]
19. Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease.
Zeng B; Prasan A; Fung KC; Solanki V; Bruce D; Freedman SB; Brieger D
Intern Med J; 2005 Jun; 35(6):331-5. PubMed ID: 15892761
[TBL] [Abstract][Full Text] [Related]
20. Effects of clopidogrel on soluble CD40 ligand and on high-sensitivity C-reactive protein in patients with stable coronary artery disease.
Azar RR; Kassab R; Zoghbi A; Aboujaoudé S; El-Osta H; Ghorra P; Germanos M; Salamé E
Am Heart J; 2006 Feb; 151(2):521.e1-521.e4. PubMed ID: 16442924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]